Renee Alsarraf,

DVM, DACVIM (Oncology)
Role: Senior Veterinarian
Specialist in Oncology
Department: Oncology
Dr. Renee Alsarraf

Dr. Renee Alsarraf received her veterinary medical degree in 1991 from Michigan State University. While there she established the University’s Pet Loss Support Group which is still in existence today. Dr. Alsarraf completed a rotating internship and medical oncology residency at the Animal Medical Center and worked at Memorial Sloan Kettering in a tissue culture lab.  She has performed numerous veterinary clinical trials, co-authored peer-reviewed journal articles, and has lectured both locally and on the national level. Dr. Alsarraf has created 4 different veterinary oncology practices as well as created and led 3 veterinary radiation facilities. She is on MSU’s Veterinary School Admissions Committee. Her acclaimed memoir Sit, Stay, Heal: What Dogs Can Teach Us About Living Well celebrates the human-animal bond in its deepest form. She has done extensive interviews about her book on national tv, local tv, podcasts and in-person events.

Dr. Alsarraf enjoys giving back to the community and has done extensive work in this sector.  Additionally, she used to compete in obedience trials with her boxers and help special needs children through horses. In her free time, she enjoys hunting for antiques, cooking, gardening, and listening to her son play the piano.

Board Certification:

  • Diplomate American College of Veterinary Internal Medicine (Oncology)


  • Residency in Medical Oncology, Animal Medical Center
  • Rotating Internship, Animal Medical Center
  • DVM, Michigan State University

Recent Publications:

Evaluation of the Tolerability of Combination Chemotherapy with Mitoxantrone and Dacarbazine in Dogs with Lymphoma. Journal of the American Animal Hospital Association: March/April 2019

Calcitriol (1,25 dihydroxycholicalciferol) Enhances Mast Cell Tumour Chemotherapy and Receptor Tyrosine Kinase Inhibitor Activity In Vitro and has Single Agent Activity Against Spontaneously Occurring Canine Mast Cell Tumours. Veterinary Comparative Oncology September 2010

Phase-II Open Label Study of Single Agent Hydroxyurea for the Treatment of Mast Cell Tumours in Dogs. Veterinary Comparative Oncology June 2010

Evaluation of Dexamethasone as a Chemoprotectant for CCNU-induced Bone Marrow Suppression in Dogs. Veterinary Comparative Oncology 2009

Combination of CCNU and DTIC Chemotherapy Treatment of Resistant Lymphoma. Journal of Veterinary Internal Medicine January 2008

Lomustine for the Treatment of Mast Cell Tumors in Cats: 38 Cases (1999-2005). Journal of Veterinary Medical Association April 2008

MOPP Chemotherapy for Treatment of Resistant Lymphoma in Dogs: A Retrospective Study of 117 Cases. Journal of Veterinary Internal Medicine Sept/Oct 2002

Use of Carboplatin for Treatment of Dogs with Malignant Melanoma: 27 (1989-2000). Journal of the American Veterinary Medical Association May 2001.

Update on Feline Vaccine-Associated Fibrosarcoma. Veterinary Medicine 1998

A Prospective Study of Radiation Therapy for the Treatment of Grade 2 Mast Cell Tumors in 32 Dogs. Journal of Veterinary Internal Medicine November 1996.

Invited editor for Veterinary Medicine (journal)

Book Chapters – invited contributor to The Five Minute Veterinary Consult textbook, edition 3 and edition 4.